Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 1

1(25.0%)

Phase 4

1(25.0%)

4Total

N/A(2)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04340180Phase 1Completed

Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction

Role: collaborator

NCT05286593Phase 4Completed

3D PET Myocardial Blood Flow and Rb82 Infusion Profiles

Role: collaborator

NCT03742453Not ApplicableUnknown

Evaluation of Diagnostic Accuracy of CEUS for HCC Diagnosis

Role: collaborator

NCT03213470Not ApplicableCompleted

Prospective Observation for Serial Changes in Acute Intracranial Artery Dissection Using HR-MRI

Role: collaborator

NCT02931331Unknown

Coronary Revascularization Assessed by Stress PET

Role: collaborator

NCT02914288Unknown

Prospective Observation for Serial Changes of Acute Intracranial Artery Dissection Using High Resolution MRI

Role: collaborator

NCT01541566Completed

Blood Pressure Control and Compliance to Treatment in Hypertensive Patients With Metabolic Syndrome: a Study Based on Home Blood Pressure Telemonitoring and Assessment of Psychological Determinants

Role: collaborator

All 7 trials loaded